PBH

#1604
Prestige Consumer Healthcare Inc. Common Stock
47.5 1 USD
-1.98%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
47.22
47.84
Intervallo Annuale
42.74
87.12
Variazione giornaliera
-1.98%
Variazione Mensile
-15.01%
Variazione di 6 mesi
-20.70%
Variazione Annuale
-43.54%
Chiusura Precedente
48.4 7
Open
47.7 6
Minimo
47.2 2
High
47.8 4
Volume
592
Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche Dividendi
Trimestrale Annuale
  • Market Capitalization 2.25 B
  • Employee 600
  • Founded 1996
  • CEO Matthew M. Mannelly
  • Website www.prestigebrands.com
  • Headquarter New York, United States
  • FIGI BBG000QM0RZ4
  • Industry Case Farmaceutiche - Specialistico e Generico
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
15.16
Rapporto prezzo/fatturato
2.79

Prestige Consumer Healthcare Inc. Common Stock

Prestige Consumer Healthcare Inc. is an American company that markets and distributes over-the-counter healthcare and household cleaning products. It was formed by the merger of Medtech Products, Inc., Prestige Brands International, and the Spic and Span Company in 1996. The company is headquartered in Tarrytown, New York and operates a manufacturing facility in Lynchburg, Virginia. Among the brands owned by Prestige are Chloraseptic sore throat products, Clear Eyes, Compound W wart treatment, Dramamine motion sickness treatment, Efferdent denture care, Luden's throat drops, BC Powder and Goody's Headache Powder, Pediacare & Little Remedies children's OTC products and Beano. The company's CEO and president is Ron Lombardi, who replaced Matthew Mannelly on June 1, 2015.

Notizie